Skip to main content

Dr. Stieglitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stieglitz's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2008 - 2011
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2008

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2024
  • NY State Medical License
    NY State Medical License 2009 - 2012
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • K08 Clinical Investigator Award NHLBI @ NIH, 2017
  • Individual Investigator Award American Cancer Society, 2016
  • Rally Grant Rally Foundation for Childhood Cancer Research, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Downregulating Notch Counteracts KrasG12D-Induced ERK Activation and Oxidative Phosphorylation in Myeloproliferative Neoplasm  
    Erik A Ranheim, David Yang, Warren S Pear, Lan Zhou, Mignon Loh, Eric Padron, Elliot Stieglitz, Nature

Abstracts/Posters

  • In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell Malignancies
    Elliot Stieglitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • DNA Methylation As a Biomarker of Outcome in JMML: An International Effort Towards Clinical Implementation
    Elliot Stieglitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Funding Lifesaving Research with Dr. Elliot Stieglitz
    Funding Lifesaving Research with Dr. Elliot StieglitzMay 22nd, 2019
  • Liver Cancer Drug for Adults Saves the Life of an Infant with Deadly Leukemia
    Liver Cancer Drug for Adults Saves the Life of an Infant with Deadly LeukemiaSeptember 12th, 2019
  • How a Powerful Genetic Test Matched an Infant’s Cancer to a Life-Saving Therapy
    How a Powerful Genetic Test Matched an Infant’s Cancer to a Life-Saving TherapySeptember 12th, 2019
  • Join now to see all

Other Languages

  • Spanish

Hospital Affiliations